Functional Service Provider (FSP) Model

Building trust and long-term strategic global partnerships

You did an amazing job in such a short time. Thank you very much for your partnership!
Program Lead
Global Pharmaceutical Sponsor

At MMS, our customer-aligned FSP teams go beyond delivery. We partner with you to find the right outsourcing model, level of oversight, scale, and governance to provide a functional sourcing solution that best suits your organization’s unique needs.

Sponsors around the globe engage with MMS as a CRO provider for FSP partnerships in the following areas:

Our FSP models are designed to be flexible and scalable, allowing MMS experts a level of engagement to adapt to your changing needs. Tailored key performance indicators (KPI), governance, and communication plans meet you where you are, as well as provide the tools and structure to achieve your long- and short-term strategic goals.

As an innovative, award-winning CRO, MMS leverages decades of evolving, long-term FSP partnerships with a commitment to process improvement, cost efficiencies, and innovation to help you succeed.

Key benefits of choosing the MMS FSP model include:

  • Experience and consistency of an FSP relationship allows MMS to bring the greatest value and specialized knowledge, rather than other transactional models
  • Effective and efficient communication plans by defining roles and responsibilities, with a clear escalation process
  • Access to global talent ensures seamless resourcing strategies and ability to meet urgent timelines due to regulatory and/or team needs
  • With a focus on innovation and technology, MMS can bring our combined service and technology solutions to build efficient processes and bring time and effort savings
  • Operational efficiencies are gained through interdependent cross-functional services in medical writing, data services, pharmacovigilance, quality control and more
  • Through value-added FSP partnerships, MMS strives for seamless collaborations that build trust

Request more information on our suite of customizable FSP solutions.

Suggested For You

webinar

July 31st, 2025

Design, Data, and Decisions in Oncology Trials

perspectives

June 24th, 2025

Why Now Is the Time for Specialized, Data-Focused CRO Partners

news

June 19th, 2025

MMS Wins in the 2025 Fierce CRO Awards for Excellence in Client Service and Partnership and Dr. Uma Sharma Named CRO Champion 

perspectives

June 17th, 2025

Solving Data Complexity with Real-Time Insights, Predictive AI, and Smarter Decision-Making with Datacise

regulatory intelligence

June 16th, 2025

Key MedDRA Coding Gaps Highlighted at the ISCTM 2025 Scientific Meeting

perspectives

June 10th, 2025

Applying Artificial Intelligence (AI) and Real-World Evidence to Boost Efficiency in Patient Safety Narratives 

perspectives

June 3rd, 2025

Choosing the Right Strategy: Parallel, Sequential, and Staggered Regulatory Submissions 

news

May 28th, 2025

MMS Named Finalist for Fierce CRO Award in Excellence in Client Service and Partnership, CEO shortlisted for the CRO Champion Award 

perspectives

May 28th, 2025

A Season of Change: Why the REMS Industry Consortium Matters More Than Ever

perspectives

May 20th, 2025

Navigating FDA OMOR Meetings: A Comprehensive Guide to Type X, Y, and Z Meetings for OTC Drug Sponsors

perspectives

May 6th, 2025

Why Clinical Trial Simulation Is Reshaping Drug Development: A Q&A with Dr. Aiden Flynn

perspectives

April 24th, 2025

How to Derisk Clinical Development with Unified Trial Design and Regulatory Strategy